Clinical Effectiveness Unit, Royal College of Surgeons, London, UK
Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, UK.
BMJ Open. 2023 Nov 21;13(11):e071674. doi: 10.1136/bmjopen-2023-071674.
We assessed how often National Health Service (NHS) hospitals reported that they had specific supportive services for patients with prostate cancer available onsite, including nursing support, sexual function and urinary continence services, psychological and genetic counselling, and oncogeriatric services. We identified groups of hospitals with similar patterns of supportive services.
DESIGN/SETTING: We conducted an organisational survey in 2021 of all NHS hospitals providing prostate cancer services in England and Wales. Latent class analysis grouped hospitals with similar patterns of supportive services.
In 138 hospitals, an advanced prostate cancer nurse was available in 125 hospitals (90.6%), 107 (77.5%) had a clinical nurse specialist (CNS) attending all clinics, 103 (75.7%) had sexual function services, 111 (81.6%) had continence services and 93 (69.4%) psychological counselling. The availability of genetic counselling (41 hospitals, 30.6%) and oncogeriatric services (15 hospitals, 11.0%) was lower. The hospitals could be divided into three groups. The first and largest group of 85 hospitals provided the most comprehensive supportive services onsite: all hospitals had a CNS attending all clinics, 84 (98.8%) sexual function services and 73 (85.9%) continence services. A key characteristic of the second group of 31 hospitals was that none had a CNS attending all clinics. A key characteristic of the third group of 22 hospitals was that none had sexual function services available. The hospitals in the largest group were more likely to run joint clinics (p<0.001) and host the regional specialist multidisciplinary team (p=0.002).
There is considerable variation in supportive services for prostate cancer available onsite in NHS hospitals in England and Wales. Availability of genetic counselling and oncogeriatric services is low. The different patterns of supportive services among hospitals demonstrate that initiatives to improve the availability of the entire range of supportive services to all patients should be carefully targeted.
我们评估了国民保健服务(NHS)医院报告其 onsite 提供特定前列腺癌患者支持服务的频率,包括护理支持、性功能和尿失禁服务、心理和遗传咨询以及肿瘤老年病学服务。我们确定了具有相似支持服务模式的医院群体。
设计/背景:我们于 2021 年对英格兰和威尔士提供前列腺癌服务的所有 NHS 医院进行了一项组织调查。潜在类别分析将具有相似支持服务模式的医院进行分组。
在 138 家医院中,125 家(90.6%)有高级前列腺癌护士,107 家(77.5%)有临床护士专家(CNS)参加所有门诊,103 家(75.7%)有性功能服务,111 家(81.6%)有尿失禁服务,93 家(69.4%)有心理咨询。遗传咨询(41 家医院,30.6%)和肿瘤老年病学服务(15 家医院,11.0%)的可用性较低。医院可分为三组。第一组也是最大的一组有 85 家医院提供了最全面的 onsite 支持服务:所有医院都有 CNS 参加所有门诊,84 家(98.8%)有性功能服务,73 家(85.9%)有尿失禁服务。第二组 31 家医院的一个关键特征是没有 CNS 参加所有门诊。第三组 22 家医院的一个关键特征是没有性功能服务。最大组的医院更有可能开设联合诊所(p<0.001)并主持区域专科多学科团队(p=0.002)。
英格兰和威尔士 NHS 医院 onsite 提供的前列腺癌支持服务存在相当大的差异。遗传咨询和肿瘤老年病学服务的可用性较低。医院之间不同的支持服务模式表明,应针对提高所有患者获得整个范围的支持服务的可用性的举措进行精心定位。